188 related articles for article (PubMed ID: 29321375)
1. Highly potent visnagin derivatives inhibit Cyp1 and prevent doxorubicin cardiotoxicity.
Asnani A; Zheng B; Liu Y; Wang Y; Chen HH; Vohra A; Chi A; Cornella-Taracido I; Wang H; Johns DG; Sosnovik DE; Peterson RT
JCI Insight; 2018 Jan; 3(1):. PubMed ID: 29321375
[TBL] [Abstract][Full Text] [Related]
2. Cyp1 Inhibition Prevents Doxorubicin-Induced Cardiomyopathy in a Zebrafish Heart-Failure Model.
Lam PY; Kutchukian P; Anand R; Imbriglio J; Andrews C; Padilla H; Vohra A; Lane S; Parker DL; Cornella Taracido I; Johns DG; Beerens M; MacRae CA; Caldwell JP; Sorota S; Asnani A; Peterson RT
Chembiochem; 2020 Jul; 21(13):1905-1910. PubMed ID: 32003101
[TBL] [Abstract][Full Text] [Related]
3. Visnagin protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenase.
Liu Y; Asnani A; Zou L; Bentley VL; Yu M; Wang Y; Dellaire G; Sarkar KS; Dai M; Chen HH; Sosnovik DE; Shin JT; Haber DA; Berman JN; Chao W; Peterson RT
Sci Transl Med; 2014 Dec; 6(266):266ra170. PubMed ID: 25504881
[TBL] [Abstract][Full Text] [Related]
4. Embryonic cardiotoxicity of weak aryl hydrocarbon receptor agonists and CYP1A inhibitor fluoranthene in the Atlantic killifish (Fundulus heteroclitus).
Brown DR; Clark BW; Garner LV; Di Giulio RT
Comp Biochem Physiol C Toxicol Pharmacol; 2016 Oct; 188():45-51. PubMed ID: 27211013
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Cyp1a Protects Mice against Anthracycline Cardiomyopathy.
Liu J; Curtin C; Lall R; Lane S; Wieke J; Ariza A; Sejour L; Vlachos I; Zordoky BN; Peterson RT; Asnani A
bioRxiv; 2024 Apr; ():. PubMed ID: 38645084
[TBL] [Abstract][Full Text] [Related]
6. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP
Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534
[TBL] [Abstract][Full Text] [Related]
7. Folic acid reduces doxorubicin-induced cardiomyopathy by modulating endothelial nitric oxide synthase.
Octavia Y; Kararigas G; de Boer M; Chrifi I; Kietadisorn R; Swinnen M; Duimel H; Verheyen FK; Brandt MM; Fliegner D; Cheng C; Janssens S; Duncker DJ; Moens AL
J Cell Mol Med; 2017 Dec; 21(12):3277-3287. PubMed ID: 28608983
[TBL] [Abstract][Full Text] [Related]
8. Visnagin: A novel cardioprotective agent against anthracycline toxicity (Review).
Obeidat O; Obeidat A; Obeidat A; Ismail MF
Med Int (Lond); 2024; 4(4):37. PubMed ID: 38799005
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of 23-hydroxybetulinic acid on doxorubicin-induced cardiotoxicity: a correlation with the inhibition of carbonyl reductase-mediated metabolism.
Zhou F; Hao G; Zhang J; Zheng Y; Wu X; Hao K; Niu F; Luo D; Sun Y; Wu L; Ye W; Wang G
Br J Pharmacol; 2015 Dec; 172(23):5690-703. PubMed ID: 25363561
[TBL] [Abstract][Full Text] [Related]
10. Calycosin attenuates doxorubicin-induced cardiotoxicity via autophagy regulation in zebrafish models.
Lu X; Lu L; Gao L; Wang Y; Wang W
Biomed Pharmacother; 2021 May; 137():111375. PubMed ID: 33761601
[TBL] [Abstract][Full Text] [Related]
11. Zebrafish cardiotoxicity: the effects of CYP1A inhibition and AHR2 knockdown following exposure to weak aryl hydrocarbon receptor agonists.
Brown DR; Clark BW; Garner LV; Di Giulio RT
Environ Sci Pollut Res Int; 2015 Jun; 22(11):8329-38. PubMed ID: 25532870
[TBL] [Abstract][Full Text] [Related]
12. Chronic doxorubicin cardiotoxicity modulates cardiac cytochrome P450-mediated arachidonic acid metabolism in rats.
Alsaad AM; Zordoky BN; El-Sherbeni AA; El-Kadi AO
Drug Metab Dispos; 2012 Nov; 40(11):2126-35. PubMed ID: 22867862
[TBL] [Abstract][Full Text] [Related]
13. Astragalus polysaccharide restores autophagic flux and improves cardiomyocyte function in doxorubicin-induced cardiotoxicity.
Cao Y; Shen T; Huang X; Lin Y; Chen B; Pang J; Li G; Wang Q; Zohrabian S; Duan C; Ruan Y; Man Y; Wang S; Li J
Oncotarget; 2017 Jan; 8(3):4837-4848. PubMed ID: 27902477
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotective action of the aqueous extract of Terminalia arjuna bark against toxicity induced by doxorubicin.
Bishop S; Liu SJ
Phytomedicine; 2017 Dec; 36():210-216. PubMed ID: 29157817
[TBL] [Abstract][Full Text] [Related]
15. Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways.
Ma J; Wang Y; Zheng D; Wei M; Xu H; Peng T
Cardiovasc Res; 2013 Jan; 97(1):77-87. PubMed ID: 23027656
[TBL] [Abstract][Full Text] [Related]
16. Plasmatic and chamber-specific modulation of cardiac microRNAs in an acute model of DOX-induced cardiotoxicity.
Gioffré S; Ricci V; Vavassori C; Ruggeri C; Chiesa M; Alfieri I; Zorzan S; Buzzetti M; Milano G; Scopece A; Castiglioni L; Sironi L; Pompilio G; Colombo GI; D'Alessandra Y
Biomed Pharmacother; 2019 Feb; 110():1-8. PubMed ID: 30453253
[TBL] [Abstract][Full Text] [Related]
17. Rac1-mediated cardiac damage causes diastolic dysfunction in a mouse model of subacute doxorubicin-induced cardiotoxicity.
Ohlig J; Henninger C; Zander S; Merx M; Kelm M; Fritz G
Arch Toxicol; 2018 Jan; 92(1):441-453. PubMed ID: 28710503
[TBL] [Abstract][Full Text] [Related]
18. Cardiac autonomic modulation induced by doxorubicin in a rodent model of colorectal cancer and the influence of fullerenol pretreatment.
Potočnik N; Perše M; Cerar A; Injac R; Finderle Ž
PLoS One; 2017; 12(7):e0181632. PubMed ID: 28727839
[TBL] [Abstract][Full Text] [Related]
19. Over-expression of calpastatin aggravates cardiotoxicity induced by doxorubicin.
Wang Y; Zheng D; Wei M; Ma J; Yu Y; Chen R; Lacefield JC; Xu H; Peng T
Cardiovasc Res; 2013 Jun; 98(3):381-90. PubMed ID: 23455548
[TBL] [Abstract][Full Text] [Related]
20. The protective effect of cardiac gene transfer of CuZn-sod in comparison with the cardioprotector monohydroxyethylrutoside against doxorubicin-induced cardiotoxicity in cultured cells.
Abou El Hassan MA; Heijn M; Rabelink MJ; van der Vijgh WJ; Bast A; Hoeben RC
Cancer Gene Ther; 2003 Apr; 10(4):270-7. PubMed ID: 12679799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
